First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes

被引:0
|
作者
Samantha Green
Sarah L. Perrott
Andrew McCleary
Isobel Sleeman
Jodi Maple-Grødem
Carl E. Counsell
Angus D. Macleod
机构
[1] University of Aberdeen,Division of Applied Health Sciences
[2] Ninewells Hospital,The Norwegian Centre for Movement Disorders
[3] Stavanger University Hospital,Department of Chemistry, Bioscience and Environmental Engineering
[4] University of Stavanger,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
To define the incidence, predictors and prognosis of the first hospital delirium episode in Parkinson’s disease (PD) and atypical parkinsonism (AP), we identified the first hospital episode of delirium after diagnosis in the Parkinsonism Incidence in North-East Scotland (PINE) study, a prospective community-based incidence cohort of parkinsonism, using chart-based criteria to define delirium. Of 296 patients (189=PD, 107=AP [dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, vascular parkinsonism]), 152 developed delirium (PD = 98, AP = 54). Incidence of first hospital delirium episode per 100 person years was 8.1 (95% confidence interval [CI] 6.6–9.9) in PD and 18.5 (95% CI 13.9–24.7) in AP. Independent predictors of delirium were atypical parkinsonism (Hazard ratio [HR] vs PD = 2.83 [95% CI 1.60–5.03], age in PD but not in AP (HR for 10-year increase 2.29 [95% CI 1.74–3.02]), baseline MMSE (HR = 0.94 [95% CI 0.89–0.99]), APOE ε4 in PD (HR 2.16 [95% CI 1.15–4.08]), and MAPT H1/H1 in PD (HR 2.08 [95% CI 1.08–4.00]). Hazards of dementia and death after delirium vs before delirium were increased (dementia: HR = 6.93 [95% CI 4.18–11.48] in parkinsonism; death: HR = 3.76 [95% CI 2.65–5.35] in PD, 1.59 [95% CI 1.04–2.42] in AP). Delirium is a common non-motor feature of PD and AP and is associated with increased hazards of dementia and mortality. Whether interventions for early identification and treatment improve outcomes requires investigation.
引用
收藏
相关论文
共 50 条
  • [41] Functional Connectome in Parkinson’s Disease and Parkinsonism
    Sule Tinaz
    Current Neurology and Neuroscience Reports, 2021, 21
  • [42] Cardiac abnormalities in Parkinson's disease and Parkinsonism
    Scorza, Fulvio A.
    Fiorini, Ana C.
    Scorza, Carla A.
    Finsterer, Josef
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 53 : 1 - 5
  • [43] Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism
    Lin, Guang
    Wang, Liping
    Marcogliese, Paul C.
    Bellen, Hugo J.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (02): : 106 - 117
  • [44] Prevalence of Parkinson's disease and parkinsonism in Kyrgyzstan
    Shambetova, C.
    MOVEMENT DISORDERS, 2019, 34
  • [45] Clinical manifestations of Parkinson's disease and parkinsonism
    Hobson, DE
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2003, 30 : S2 - S9
  • [46] Transcranial sonography in parkinson's disease and parkinsonism
    Durmaz, Seyma
    Kursun, Oguzhan
    Oztekin, Nese
    Karadag, Yesim
    NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2023, 40 (04): : 200 - 206
  • [47] Clinical neurophysiology of Parkinson's disease and parkinsonism
    Chen, Robert
    Berardelli, Alfredo
    Bhattacharya, Amitabh
    Bologna, Matteo
    Chen, Kai-Hsiang Stanley
    Fasano, Alfonso
    Helmich, Rick C.
    Hutchison, William D.
    Kamble, Nitish
    Kuehn, Andrea A.
    Macerollo, Antonella
    Neumann, Wolf-Julian
    Pal, Pramod Kumar
    Paparella, Giulia
    Suppa, Antonio
    Udupa, Kaviraja
    CLINICAL NEUROPHYSIOLOGY PRACTICE, 2022, 7 : 201 - 227
  • [48] Transcranial Sonography in Parkinson's Disease and Parkinsonism
    Lee, Won Yong
    Kim, Ji Youn
    Kim, Seong Tae
    JOURNAL OF MOVEMENT DISORDERS, 2008, 1 (01) : 6 - 12
  • [49] Motor symptoms in Parkinsonism and Parkinson's disease
    Grabli, David
    PRESSE MEDICALE, 2017, 46 (02): : 187 - 194
  • [50] Neuroimaging of Parkinson's disease and atypical parkinsonism
    Zgaljardic D.J.
    Feigin A.
    Current Neurology and Neuroscience Reports, 2004, 4 (4) : 284 - 289